Goldman Sachs
SRTA

Goldman Sachs’s Strata Critical Medical Inc SRTA Stock Holding History

Goldman Sachs’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.48M Buy
471,528
+57,083
+14% +$300K ﹤0.01% 4503
2026
Q1 		$1.73M Sell
414,445
-59,079
-12% -$284K ﹤0.01% 4663
2025
Q4 		$2.28M Buy
473,524
+219,730
+87% +$1.06M ﹤0.01% 4462
2025
Q3 		$1.28M Buy
253,794
+56,140
+28% +$248K ﹤0.01% 4856
2025
Q2 		$797K Sell
197,654
-68,760
-26% -$224K ﹤0.01% 4860
2025
Q1 		$727K Sell
266,414
-106,618
-29% -$382K ﹤0.01% 4932
2024
Q4 		$1.59M Sell
373,032
-60,024
-14% -$229K ﹤0.01% 4493
2024
Q3 		$1.27M Sell
433,056
-10,776
-2% -$34.3K ﹤0.01% 4471
2024
Q2 		$1.54M Buy
443,832
+274,984
+163% +$917K ﹤0.01% 4126
2024
Q1 		$481K Sell
168,848
-24,546
-13% -$75.7K ﹤0.01% 4766
2023
Q4 		$683K Buy
193,394
+75,199
+64% +$216K ﹤0.01% 4587
2023
Q3 		$306K Sell
118,195
-1,837,957
-94% -$6.46M ﹤0.01% 4889
2023
Q2 		$7.71M Sell
1,956,152
-637,180
-25% -$2.02M ﹤0.01% 2701
2023
Q1 		$8.77M Buy
2,593,332
+2,502,510
+2,755% +$10.2M ﹤0.01% 2539
2022
Q4 		$325K Buy
90,822
+49,846
+122% +$213K ﹤0.01% 5102
2022
Q3 		$165K Buy
40,976
+28,615
+231% +$147K ﹤0.01% 5544
2022
Q2 		$55K Sell
12,361
-212,063
-94% -$1.53M ﹤0.01% 6011
2022
Q1 		$1.91M Buy
224,424
+35,047
+19% +$246K ﹤0.01% 4309
2021
Q4 		$1.67M Buy
+189,377
New +$1.8M ﹤0.01% 4403
2021
Q1 		– Sell
-23,529
Closed -$261K – 6083
2020
Q4 		$261K Sell
23,529
-51,471
-69% -$525K ﹤0.01% 4954
2020
Q3 		$754K Buy
+75,000
New +$757K ﹤0.01% 4259

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs's SRTA Position: Q2 2026 in Review

Goldman Sachs increased its Strata Critical Medical Inc (SRTA) stake by 14% in Q2 2026, buying an estimated $300K and bringing the position to 471,528 shares worth $2.48M. The position accounts for ﹤0.01% of the portfolio, ranked #4503.

Goldman Sachs first reported a position in SRTA in Q3 2020 and has held it in 21 quarters since. The position peaked at $8.77M in Q1 2023. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Goldman Sachs held 471,528 shares of Strata Critical Medical Inc worth $2.48M as of Q2 2026.
  • Goldman Sachs bought 57,083 Strata Critical Medical Inc shares in Q2 2026, an estimated $300K.
  • Strata Critical Medical Inc made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4503 holding.
  • Goldman Sachs first reported a position in Strata Critical Medical Inc in Q3 2020 and has held it in 21 quarters since.
  • Goldman Sachs's Strata Critical Medical Inc position peaked at $8.77M in Q1 2023.
  • 140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.